Background Hepatocellular carcinoma is one of the most common cancers and the second leading cause of cancer-related deaths worldwide. Only a small proportion of patients benefit from curative treatment and the prognosis is very poor for the majority of cases due to late presentation, resistance to chemotherapy and high recurrence rate. In recent years, progress in stem cell biology allowed us to explain that hierarchically organized cancer stem cells (CSCs) drive histological and functional heterogeneity of hematological malignancies and solid tumors
none5noHepatocellular carcinoma (HCC) is one of the deadliest cancers. HCC is associated with multip...
The two dominant models of carcinogenesis postulate stochastic (clonal evolution) or hierarchic orga...
SummaryThe human liver consists of three types of liver cells: mature hepatocytes, cholangiocytes, a...
Background Hepatocellular carcinoma is one of the most common cancers and the second leading cause o...
Hepatocellular carcinoma (HCC) accounts for approximately 6% of all new cancer cases diagnosed, and ...
This article belongs to the Special Issue Liver Cancer and Potential Therapeutic Targets.The recogni...
Liver cancer is an aggressive disease with a poor outcome. Several hepatic stem/progenitor markers a...
Recent studies indicated the importance of stem cells in cancer, including in hepatocellular carcino...
The cancer stem cell (CSC) hypothesis was proposed over 4 decades ago and states that tumor growth i...
The poor clinical outcome of hepatocellular carcinoma (HCC) patients is ascribed to the resistance o...
Subsequent to an initiating event, tumor promotion requires sustained cell proliferation to allow fo...
Hepatocellular carcinoma (HCC) is the third most common cause of cancer-related mortality in the wor...
In the past decade, the hypothesis of tumor-initiating cell (TIC) or cancer stem cell (CSC)-driven t...
Aiwu Ruth He,1 Daniel C Smith,1 Lopa Mishra2 1Lombardi Comprehensive Cancer Center, Georgetown Unive...
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer death globally. The cancer ste...
none5noHepatocellular carcinoma (HCC) is one of the deadliest cancers. HCC is associated with multip...
The two dominant models of carcinogenesis postulate stochastic (clonal evolution) or hierarchic orga...
SummaryThe human liver consists of three types of liver cells: mature hepatocytes, cholangiocytes, a...
Background Hepatocellular carcinoma is one of the most common cancers and the second leading cause o...
Hepatocellular carcinoma (HCC) accounts for approximately 6% of all new cancer cases diagnosed, and ...
This article belongs to the Special Issue Liver Cancer and Potential Therapeutic Targets.The recogni...
Liver cancer is an aggressive disease with a poor outcome. Several hepatic stem/progenitor markers a...
Recent studies indicated the importance of stem cells in cancer, including in hepatocellular carcino...
The cancer stem cell (CSC) hypothesis was proposed over 4 decades ago and states that tumor growth i...
The poor clinical outcome of hepatocellular carcinoma (HCC) patients is ascribed to the resistance o...
Subsequent to an initiating event, tumor promotion requires sustained cell proliferation to allow fo...
Hepatocellular carcinoma (HCC) is the third most common cause of cancer-related mortality in the wor...
In the past decade, the hypothesis of tumor-initiating cell (TIC) or cancer stem cell (CSC)-driven t...
Aiwu Ruth He,1 Daniel C Smith,1 Lopa Mishra2 1Lombardi Comprehensive Cancer Center, Georgetown Unive...
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer death globally. The cancer ste...
none5noHepatocellular carcinoma (HCC) is one of the deadliest cancers. HCC is associated with multip...
The two dominant models of carcinogenesis postulate stochastic (clonal evolution) or hierarchic orga...
SummaryThe human liver consists of three types of liver cells: mature hepatocytes, cholangiocytes, a...